Loading...
XSHE
000153
Market cap445mUSD
Aug 28, Last price  
6.45CNY
Name

Anhui Fengyuan Pharmaceutical Co Ltd

Chart & performance

D1W1MN
XSHE:000153 chart
P/E
30.15
P/S
0.78
EPS
0.21
Div yield, %
1.55%
Shrs. gr., 5y
1.24%
Rev. gr., 5y
1.10%
Revenues
Net income
CFO
Dividend
Jun 18, 20260.1 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Hefei, China in 1997, Anhui Fengyuan Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise engaged in the research, development, manufacturing, and distribution of a wide array of medicinal products. The company primarily serves the Chinese market, offering biological pharmaceuticals, chemical drugs, and traditional Chinese medicines. Its extensive product portfolio addresses numerous health concerns, including pain and fever relief, cardiovascular conditions, infections, neurological disorders, cancer, ulcers, and hormonal imbalances. Fengyuan Pharmaceutical also produces nutritional supplements, treatments for vitamin and mineral deficiencies, anti-parasitic and antimicrobial agents, coenzymes, antiviral medications, and uterine contractants. Furthermore, its offerings encompass sedative-hypnotics, drugs for irritable bowel syndrome, hypertension treatments, and remedies for benign prostatic hyperplasia. Beyond its domestic operations, the company exports its pharmaceutical goods to international markets such as Europe, North America, Africa, Southeast Asia, and Central Asia.
IPO date
Sep 20, 2000
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

No data to show